[CAS NO. 1801873-49-3]  OICR-0547

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1801873-49-3]

Catalog
HY-16994
Brand
MCE
CAS
1801873-49-3

DESCRIPTION [1801873-49-3]

Overview

MDL-
Molecular Weight542.55
Molecular FormulaC28H29F3N4O4
SMILESO=C(C1=CNC(C=C1C(F)(F)F)=O)NC2=CC(C3=CC(CN4CCOCC4)=CC=C3)=CC=C2N5CCOCC5

For research use only. We do not sell to patients.

Summary

OICR-0547 is a negative control , closely related derivative of OICR-9429 (HY-16993). OICR-9429 is a novel small-molecule antagonist of the Wdr5-MLL interaction. OICR-0547 is an inactive control compound that no longer binds to WDR5 [1] [2] .


In Vitro

OICR-0547 does not bind to WDR5 [1] .
OICR-0547(0.1-100 μM) has no effect on cellular viability [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay [1]

Cell Line: K562 cells and Cebpa p30/p30 cells
Concentration: 0.1-100 μM
Incubation Time:
Result: Induced non-selective toxicity at high doses in both cell types.

In Vivo

OICR-0547 (i.v, i.p.; 3, 30 mg/kg) is a suitable negative control in NOD-SCID Mice [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: NOD-SCID Mice (female) [2]
Dosage: 3, 30 mg/kg
Administration: IV, IP
Result: Served as a suitable negative control for biological experiments.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : ≥ 100 mg/mL ( 184.31 mM )

* "≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.8431 mL 9.2157 mL 18.4315 mL
5 mM 0.3686 mL 1.8431 mL 3.6863 mL
10 mM 0.1843 mL 0.9216 mL 1.8431 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.5 mg/mL (4.61 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (4.61 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.5 mg/mL (4.61 mM); Clear solution

* All of the co-solvents are available by MCE.